Skip to content

US · DCGO · MEDICAL - CARE FACILITIES

DocGo Inc. (DCGO) intrinsic value and stock valuation

$0.18as of 2026-11-21 · Mkt cap 62.01M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

DocGo Inc. DCF and intrinsic value

InvestorsCraft values DCGO with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from DCGO’s statements →

DocGo Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Care Facilities New York City, NY 10001 docgo.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$322.2M+27.9% 5y CAGRd
20192025
Net income
-$-182.4M
20192025
Free cash flow
$27M
20192025
Total equity
$125.9M+13.5% 5y CAGRd
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$322.2M$616.6M$624.3M$440.5M$318.7M
Operating income-$-89.16M$28.7M$15.1M$21.8M$15.4M
Net income-$-182.4M$20M$6.86M$34.6M$23.7M
EPSd-$-1.84M$182.7K$64.9K$335.8K$250.3K
Operating cash flow$34.5M$70.3M-$-64.22M$28.9M-$-1.95M
Capital expenditure-$-7.43M-$-5.84M-$-10.13M-$-5.5M-$-6.66M
Free cash flow$27M$64.5M-$-74.35M$23.4M-$-8.6M
Total assets$217.1M$455.6M$490.5M$393.3M$309.6M
Total debt$29.2M$57.2M$46.5M$19.9M$16.5M
Net debt-$-21.84M-$-32.05M-$-12.79M-$-137.42M-$-159.03M
Total equity$125.9M$315.2M$305.2M$278.9M$227.1M
Cash and short-term investments$51M$89.2M$59.3M$157.3M$175.5M
Income statement
20252024202320222021
Revenue$322.2M$616.6M$624.3M$440.5M$318.7M
Cost of revenue$223.4M$403M$428.9M$285.8M$209M
Gross profit$98.8M$213.6M$195.4M$154.7M$109.8M
Research and development expenses$13.6M$11.6M$10.9M$5.38M$3.32M
Selling, general and administrative expenses$158.7M$157.4M$153M$116.9M$83.6M
Other expenses$15.7M$15.9M$16.4M$10.6M$7.51M
Operating expenses$187.9M$184.9M$180.3M$132.9M$94.4M
Cost and expenses$411.4M$587.9M$609.2M$418.7M$303.4M
Interest income$0.00$240K$1.68M$760K$0.00
Interest expense$1.01M$2.17M$0.00$0.00$760K
Depreciation and amortization$15.7M$15.9M$16.4M$10.6M$7.51M
Ebitda-$-170.82M$45.6M$32.7M$33.4M$28.1M
Operating income-$-89.16M$28.7M$15.1M$21.8M$15.4M
Total other income/expenses, net-$-98.34M-$-940K$1.24M$950K$4.44M
Income before tax-$-187.5M$27.8M$16.3M$22.8M$19.8M
Income tax expense$8.87M$14.4M$6.24M-$-7.96M$620K
Net income-$-182.4M$20M$6.86M$34.6M$23.7M
Weighted average shares outstanding$99.1M$102.4M$103.5M$101.2M$80.3M
Weighted average diluted shares outstanding$99.1M$109.4M$105.6M$103M$94.9M
Balance sheet
20252024202320222021
Cash and short-term investments$51M$89.2M$59.3M$157.3M$175.5M
Net receivables$92.9M$210.9M$262.1M$103M$78.4M
Inventory$0.00$0.00$0.00$4.48M$0.00
Total current assets$152.4M$304.5M$338.9M$271.1M$256M
Property, plant and equipment, net$43.5M$42.2M$38.4M$39.4M$26.2M
Goodwill and intangible assets$0.00$73.2M$85.2M$61.9M$19.4M
Long-term investments$0.00$5.55M$550K$600K$4.16M
Total non-current assets$64.7M$151.1M$151.6M$122.2M$53.6M
Total assets$217.1M$455.6M$490.5M$393.3M$309.6M
Accounts payable$11.1M$28.4M$19.8M$21.6M$15.8M
Short-term debt$10.2M$38.6M$31.3M$5.72M$5.36M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$67.5M$121.8M$170.1M$100.2M$57.9M
Long-term debt$19M$18.6M$15.2M$14.2M$11.2M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$23.7M$18.6M$15.2M$14.2M$24.7M
Capital lease obligations$28.9M$27.2M$21.4M$18M$14.6M
Total liabilities$91.2M$140.4M$185.3M$114.4M$82.6M
Common stock$10K$10K$10K$10K$10K
Retained earnings-$-183.8M-$-1.4M-$-21.39M-$-28.97M-$-63.56M
Accumulated other comprehensive income (loss)$2.39M$1.22M$1.48M$740K-$-30K
Total equity$125.9M$315.2M$305.2M$278.9M$227.1M
Total investments$0.00$5.55M$550K$600K$4.16M
Total debt$29.2M$57.2M$46.5M$19.9M$16.5M
Net debt-$-21.84M-$-32.05M-$-12.79M-$-137.42M-$-159.03M
Cash flow statement
20252024202320222021
Net income-$-196.37M$20M$6.86M$30.7M$19.2M
Depreciation and amortization$15.7M$15.9M$16.4M$10.6M$7.07M
Stock-based compensation$17.4M$13.6M$21M$8.05M$1.38M
Change in working capital$81.7M$19.5M-$-113.12M-$-13.18M-$-28.8M
Accounts receivable$112.5M$41.3M-$-160.52M-$-8.42M-$-58M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable-$-17.64M$8.56M-$-1.78M$3.64M$11.9M
Net cash provided by operating activities$34.5M$70.3M-$-64.22M$28.9M-$-1.95M
Investments in property, plant and equipment-$-4.54M-$-3.83M-$-7.58M-$-3.2M-$-4.81M
Acquisitions, net-$-16.4M-$-310K-$-19.46M-$-32.95M-$-1.96M
Net cash used for investing activities-$-39.08M-$-10.87M-$-29.88M-$-38.45M-$-8.59M
Common stock issued$0.00$0.00$1.58M$0.00$178.1M
Common stock repurchased-$-10.83M-$-13.76M$0.00-$-3.73M-$-480K
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-50.82M-$-24.15M$1.12M-$-6.18M$155.2M
Net change in cash-$-54.85M$35.1M-$-91.89M-$-15M$144.7M
Cash at end of period$52.5M$107.3M$72.2M$164.1M$179.1M
Operating cash flow$34.5M$70.3M-$-64.22M$28.9M-$-1.95M
Capital expenditure-$-7.43M-$-5.84M-$-10.13M-$-5.5M-$-6.66M
Free cash flow$27M$64.5M-$-74.35M$23.4M-$-8.6M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About DocGo Inc.

        DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.

        CEO
        Lee Bienstock
        Employees
        3.57K
        Beta
        1.02

        Explore

        Frequently asked questions

        What is the intrinsic value of DocGo Inc. (DCGO)?

        InvestorsCraft does not currently publish an intrinsic value for DCGO. How the IC value is calculated.

        Is DCGO undervalued?

        InvestorsCraft does not publish an undervaluation signal for DCGO at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.